Kinney Gene G.'s most recent trade in Prothena Corporation plc was a trade of 140,000 Ordinary Shares, par value $0.01 per share done . Disclosure was reported to the exchange on July 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Prothena Corporation plc | Gene G. Kinney | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2025 | 140,000 | 152,793 (0%) | 0% | 0 | Ordinary Shares, par value $0.01 per share | |
| Prothena Corporation plc | Gene G. Kinney | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 375,000 | 375,000 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Kinney Gene G. | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 307,000 | 307,000 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Gene G. Kinney | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.81 per share. | 17 May 2023 | 45,000 | 57,793 (0%) | 0% | 29.8 | 1,341,450 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Gene G. Kinney | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 45,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Gene G. Kinney | President and CEO | Sale of securities on an exchange or to another person at price $ 73.60 per share. | 17 May 2023 | 19,864 | 27,727 (0%) | 0% | 73.6 | 1,462,070 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Gene G. Kinney | President and CEO | Sale of securities on an exchange or to another person at price $ 74.49 per share. | 17 May 2023 | 14,934 | 12,793 (0%) | 0% | 74.5 | 1,112,501 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Gene G. Kinney | President and CEO | Sale of securities on an exchange or to another person at price $ 72.70 per share. | 17 May 2023 | 10,202 | 47,591 (0%) | 0% | 72.7 | 741,721 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Gene G. Kinney | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 155,000 | 155,000 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Gene G. Kinney | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Gene G. Kinney | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Gene G. Kinney | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2021 | 187,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Prothena Corporation plc | Gene G. Kinney | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 140,601 | 140,601 | - | - | Employee Stock Option (Right to Buy) | |
| Prothena Corporation plc | Gene G. Kinney | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2021 | 120,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Prothena Corporation plc | Gene G. Kinney | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2021 | 65,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Prothena Corporation plc | Gene G. Kinney | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2021 | 65,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Prothena Corporation plc | Gene G. Kinney | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 62,500 | 62,500 | - | - | Employee Stock Option (Right to Buy) | |
| Prothena Corporation plc | Gene G. Kinney | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 59,090 | 59,090 | - | - | Employee Stock Option (Right to Buy) | |
| Prothena Corporation plc | Gene G. Kinney | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2021 | 50,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Prothena Corporation plc | Gene G. Kinney | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 40,625 | 40,625 | - | - | Employee Stock Option (Right to Buy) | |
| Prothena Corporation plc | Gene G. Kinney | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2021 | 30,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Prothena Corporation plc | Gene G. Kinney | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 25,125 | 25,125 | - | - | Employee Stock Option (Right to Buy) | |
| Prothena Corporation plc | Gene G. Kinney | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 16,759 | 16,759 | - | - | Employee Stock Option (Right to Buy) |